Arrow Mark Colorado Holdings LLC Krystal Biotech, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

  • $7.59 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$37.03 - $60.0 $1.13 Million - $1.83 Million
-30,544 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$19.86 - $32.9 $36,165 - $59,910
1,821 Added 6.34%
30,544 $1.01 Million
Q4 2018

Feb 14, 2019
BUY
$15.03 - $25.38 $431,706 - $728,989
28,723 New
28,723 $597,000

Others Institutions Holding KRYS

# of Institutions
266
Shares Held
25M
Call Options Held
270K
Put Options Held
172K
View Full List

About Krystal Biotech, Inc.

KRYS Quotes by TradingView
  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.55B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email